These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 23378706)

  • 1. Chemical peels for melasma in dark-skinned patients.
    Sarkar R; Bansal S; Garg VK
    J Cutan Aesthet Surg; 2012 Oct; 5(4):247-53. PubMed ID: 23378706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tretinoin peels versus glycolic acid peels in the treatment of Melasma in dark-skinned patients.
    Khunger N; Sarkar R; Jain RK
    Dermatol Surg; 2004 May; 30(5):756-60; discussion 760. PubMed ID: 15099320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of melasma with topical agents, peels and lasers: an evidence-based review.
    Rivas S; Pandya AG
    Am J Clin Dermatol; 2013 Oct; 14(5):359-76. PubMed ID: 23881551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lactic acid chemical peels as a new therapeutic modality in melasma in comparison to Jessner's solution chemical peels.
    Sharquie KE; Al-Tikreety MM; Al-Mashhadani SA
    Dermatol Surg; 2006 Dec; 32(12):1429-36. PubMed ID: 17199649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of hydroquinone (2%) versus tretinoin (0.025%) as adjunct topical agents for chemical peeling in patients of melasma.
    Nanda S; Grover C; Reddy BS
    Dermatol Surg; 2004 Mar; 30(3):385-8; discussion 389. PubMed ID: 15008866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The combination of glycolic acid peels with a topical regimen in the treatment of melasma in dark-skinned patients: a comparative study.
    Sarkar R; Kaur C; Bhalla M; Kanwar AJ
    Dermatol Surg; 2002 Sep; 28(9):828-32; discussion 832. PubMed ID: 12269877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solution of Azelaic Acid (20%), Resorcinol (10%) and Phytic Acid (6%) Versus Glycolic Acid (50%) Peeling Agent in the Treatment of Female Patients with Facial Melasma.
    Faghihi G; Taheri A; Shahmoradi Z; Nilforoushzadeh MA
    Adv Biomed Res; 2017; 6():9. PubMed ID: 28299301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Evaluation of Efficacy and Tolerability of Glycolic Acid, Salicylic Mandelic Acid, and Phytic Acid Combination Peels in Melasma.
    Sarkar R; Garg V; Bansal S; Sethi S; Gupta C
    Dermatol Surg; 2016 Mar; 42(3):384-91. PubMed ID: 26859648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycolic acid peel therapy - a current review.
    Sharad J
    Clin Cosmet Investig Dermatol; 2013 Nov; 6():281-8. PubMed ID: 24399880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined chemical peels versus trichloroacetic acid (TCA) for treating melasma: a split face study.
    Atwa MA; Ahmed AH; Nada HA; Refaey SM; Jafferany M; Elsaie ML
    J Dermatolog Treat; 2022 Mar; 33(2):959-964. PubMed ID: 32649234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Standard guidelines of care for chemical peels.
    Khunger N;
    Indian J Dermatol Venereol Leprol; 2008 Jan; 74 Suppl():S5-12. PubMed ID: 18688104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Advanced, Physician-Strength Retinol Peel Improves Signs of Aging and Acne Across a Range of Skin Types Including Melasma and Skin of Color.
    Sadick N; Edison BL; John G; Bohnert KL; Green B
    J Drugs Dermatol; 2019 Sep; 18(9):918-923. PubMed ID: 31524348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lactic acid as a new therapeutic peeling agent in melasma.
    Sharquie KE; Al-Tikreety MM; Al-Mashhadani SA
    Dermatol Surg; 2005 Feb; 31(2):149-54; discussion 154. PubMed ID: 15762205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lasers for treatment of melasma and post-inflammatory hyperpigmentation.
    Arora P; Sarkar R; Garg VK; Arya L
    J Cutan Aesthet Surg; 2012 Apr; 5(2):93-103. PubMed ID: 23060704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of serial glycolic acid peels and a topical regimen in the treatment of recalcitrant melasma.
    Erbil H; Sezer E; Taştan B; Arca E; Kurumlu Z
    J Dermatol; 2007 Jan; 34(1):25-30. PubMed ID: 17204097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of chemical peeling as a single agent for melasma in dark-skinned patients: A systematic review and meta-analysis of comparative trials.
    Dorgham NA; Hegazy RA; Sharobim AK; Dorgham DA
    J Cosmet Dermatol; 2020 Nov; 19(11):2812-2819. PubMed ID: 32947652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical peels in the treatment of acne: patient selection and perspectives.
    Castillo DE; Keri JE
    Clin Cosmet Investig Dermatol; 2018; 11():365-372. PubMed ID: 30038512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative evaluation of beneficiary effects of priming agents (2% hydroquinone and 0.025% retinoic acid) in the treatment of melasma with glycolic acid peels.
    Garg VK; Sarkar R; Agarwal R
    Dermatol Surg; 2008 Aug; 34(8):1032-9; discussion 1340. PubMed ID: 18430172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical peeling in ethnic/dark skin.
    Roberts WE
    Dermatol Ther; 2004; 17(2):196-205. PubMed ID: 15113287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined trichloroacetic acid peel and topical ascorbic acid versus trichloroacetic acid peel alone in the treatment of melasma: a comparative study.
    Soliman MM; Ramadan SA; Bassiouny DA; Abdelmalek M
    J Cosmet Dermatol; 2007 Jun; 6(2):89-94. PubMed ID: 17524124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.